Eli Lilly-Boehringer's Jardiance for children with type 2 diabetes accepted by USFDA Ruchika Sharma10 March 2023 12:23 PM ISTIndianapolis: Boehringer Ingelheim and Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has accepted a...
USFDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease: Eli Lilly Ruchika Sharma22 Jan 2023 12:00 PM ISTIndianapolis: The U.S. Food and Drug Administration (USFDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin)...
Heartburn drug: Sanofi expects decision on Zantac dispute with Boehringer in Q1 at earliest Ruchika Sharma5 Jan 2023 1:15 PM ISTOriginally marketed by a forerunner of GSK, the medicine has been sold at different times by companies including Pfizer, Boehringer, and Sanofi as...
Boehringer Ingelheim appoints Shashank Deshpande, Paola Casarosa to Board of Managing Directors Ruchika Sharma22 Dec 2022 12:45 PM ISTThe appointment to the Board of Managing Directors will be effective July 1, 2023 for Paola Casarosa and September 1, 2023 for Shashank Deshpande.
US Federal Court assures safety from Ranitidine, dismisses 2,500 lawsuits alleging cancer linkage with drug Ruchika Sharma19 Dec 2022 3:48 PM ISTThe court ruling comes as a big win for pharmaceutical companies like Pfizer, Sanofi, GSK and Boehringer Ingelheim.
Torrent Pharma collaborates with Boehringer Ingelheim India to co-market its anti-diabetic drug, its fixed dose combinations in India Ruchika Sharma14 Dec 2022 4:50 PM ISTAhmedabad: Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Private Limited to co-market Cospiaq...
Boehringer Ingelheim gets European Commission approval for Generalized Pustular Psoriasis flares treatment Spesolimab Ruchika Sharma14 Dec 2022 2:15 PM ISTPeople living with GPP often do not receive a correct or timely diagnosis and may have their symptoms identified as other forms of psoriasis.
Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits Ruchika Sharma7 Dec 2022 1:10 PM ISTA Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...
AbbVie receives EMA Committee positive opinion for Crohn's Disease treatment Risankizumab Ruchika Sharma21 Sept 2022 3:30 PM ISTSKYRIZI is an interleukin-23 (IL-23) inhibitor that selectively blocks IL-23 by binding to its p19 subunit.
Drug Alert: CDSCO flags 45 formulations as not of standard quality Roshni Dhar20 Sept 2022 5:32 PM ISTIn its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 45 medicine batches for...
Health Bulletin 20/September/2022 Roshni Dhar20 Sept 2022 5:27 PM ISTHere are the top health news for the day:Bengaluru: Doctor shares nude pictures of fiancee for fun, killedA 27-year-old doctor was beaten to death by...
Drug Alert: CDSCO Flags 45 Formulations As Not Of Standard Quality Susmita Roy18 Sept 2022 11:30 AM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 45 medicine...
